PyInvesting

Market research

THYROCARE.NSE Thyrocare Technologies Limited

NSE INR Healthcare

Latest close

488.95 —

As of Nov 11, 2026

Test a moving-average rule with historical data.

Market facts

Market cap
78B
P/E ratio
54.51
Analyst target
687
Dividend yield
1.4%
Beta
0.5

Community

Investor discussion

1 comment

Admin profile picture
Admin

Apr 1, 2021

Thyrocare Technologies Limited is currently in a long term uptrend where the price is trading 30.7% above its 200 day moving average.

From a valuation standpoint, the stock is 150.6% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 12.0.

Thyrocare Technologies Limited's total revenue rose by 30.7% to $1B since the same quarter in the previous year.

Its net income has increased by 17.8% to $324M since the same quarter in the previous year.

Finally, its free cash flow fell by 75.3% to $221M since the same quarter in the previous year.

Based on the above factors, Thyrocare Technologies Limited gets an overall score of 3/5.